Literature DB >> 10666416

Rapid activation of neutral sphingomyelinase by hypoxia-reoxygenation of cardiac myocytes.

O M Hernandez1, D J Discher, N H Bishopric, K A Webster.   

Abstract

Elevated levels of oxygen free radicals have been implicated in the pathways of reperfusion injury to myocardial tissue. The targets for free radicals may include specific as well as random intracellular components, and part of the cellular response is the induction of extracellularly activated and stress-activated kinases. The intermediate signals that initiate these stress responses are not known. Here we show that one of the earliest responses of cardiac myocytes to hypoxia and reoxygenation is the activation of neutral sphingomyelinase and accumulation of ceramide. Ceramide increased abruptly after reoxygenation, peaking at 10 minutes with 225+/-40% of the control level. Neutral sphingomyelinase activity was induced with similar kinetics, and both activities remained elevated for several hours. c-Jun N-terminal kinase (JNK) was also activated within the same time frame. Treatment of cardiac myocytes with extracellular ceramides also activated JNK. Pretreating cells with antioxidants quenched sphingomyelinase activation, ceramide accumulation, and JNK activation. Ceramide did not accumulate in reoxygenated nonmuscle fibroblasts, and JNK was not activated by reoxygenation in these cells. The results identify neutral sphingomyelinase activation as one of the earliest responses of cardiac myocytes to the redox stress imposed by hypoxia-reoxygenation. The results are consistent with a pathway of ceramide-mediated activation of JNK.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666416     DOI: 10.1161/01.res.86.2.198

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  33 in total

Review 1.  Protective responses in the ischemic myocardium.

Authors:  R S Williams; I J Benjamin
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

2.  Plasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by sphingosine-1-phosphate mediated mechanisms.

Authors:  Eric Norman; Roy G Cutler; Richard Flannery; Yue Wang; Mark P Mattson
Journal:  J Neurochem       Date:  2010-04-29       Impact factor: 5.372

Review 3.  Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle.

Authors:  Mariana N Nikolova-Karakashian; Michael B Reid
Journal:  Antioxid Redox Signal       Date:  2011-06-08       Impact factor: 8.401

4.  Increased de novo ceramide synthesis and accumulation in failing myocardium.

Authors:  Ruiping Ji; Hirokazu Akashi; Konstantinos Drosatos; Xianghai Liao; Hongfeng Jiang; Peter J Kennel; Danielle L Brunjes; Estibaliz Castillero; Xiaokan Zhang; Lily Y Deng; Shunichi Homma; Isaac J George; Hiroo Takayama; Yoshifumi Naka; Ira J Goldberg; P Christian Schulze
Journal:  JCI Insight       Date:  2017-05-04

Review 5.  Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites.

Authors:  Astrid E Alewijnse; Stephan L M Peters; Martin C Michel
Journal:  Br J Pharmacol       Date:  2004-10-25       Impact factor: 8.739

Review 6.  The roles of neutral sphingomyelinases in neurological pathologies.

Authors:  Charles R Horres; Yusuf A Hannun
Journal:  Neurochem Res       Date:  2012-01-12       Impact factor: 3.996

Review 7.  Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.

Authors:  Catherine Pavoine; Françoise Pecker
Journal:  Cardiovasc Res       Date:  2009-01-28       Impact factor: 10.787

8.  Nitric oxide and promotion of cardiac myocyte apoptosis.

Authors:  Péter Andréka; Thanh Tran; Keith A Webster; Nanette H Bishopric
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

Review 9.  Ceramide: a common pathway for atherosclerosis?

Authors:  Jean Bismuth; Peter Lin; Qizhi Yao; Changyi Chen
Journal:  Atherosclerosis       Date:  2007-10-25       Impact factor: 5.162

10.  Induction of the matricellular protein CCN1 through RhoA and MRTF-A contributes to ischemic cardioprotection.

Authors:  Xia Zhao; Eric Y Ding; Olivia M Yu; Sunny Y Xiang; Valerie P Tan-Sah; Bryan S Yung; Joe Hedgpeth; Richard R Neubig; Lester F Lau; Joan Heller Brown; Shigeki Miyamoto
Journal:  J Mol Cell Cardiol       Date:  2014-08-08       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.